Facebook bought leverage. Synthes and Liebel changed pending patent language after seeing competitor products. The public records show both the power and the limits of those strategies.
Yahoo sued Facebook on March 12, 2012. The lawsuit targeted advertising, social networking, privacy, customization, and messaging. The disputed products and services reached the machinery that made Facebook valuable.
Facebook did not redesign its business around Yahoo’s patents. It defended the lawsuit, said Yahoo used ten Facebook patents, and expanded its patent holdings while the dispute was active.
The dispute ended in less than four months.
Two medical-device cases reveal another strategy. Synthes and Liebel-Flarsheim both changed pending patent language after competitor products appeared. Their efforts reached the competitor’s design, but the resulting patents could not survive because the original technical descriptions did not support the later breadth.
The three public records show how sophisticated companies create Freedom to Invent. The companies acquire leverage, preserve patent applications that can respond to the market, and write early technical descriptions for the competitive positions they may need later.
The records share one organizing principle. The patents are designed around the business, not the company’s current product. Facebook needed negotiating leverage. Synthes and Liebel wanted patent positions that reached products already selling in the market.
The records also show the boundary. Later patent language cannot repair technical work that the original application never described.
Facebook Turned a One-Sided Threat Into Mutual Exposure
Yahoo sued Facebook on March 12, 2012, while Facebook was preparing for its initial public offering. Yahoo asserted ten patents against core parts of Facebook’s business, including advertising, privacy, messaging, social networking, and customization.[1]
The dispute did not concern an irrelevant feature. Yahoo pointed its patents at the machinery that made Facebook valuable.
Facebook was badly outgunned on patent count. According to Cooley, the firm that represented Facebook in the dispute, Facebook had 56 issued U.S. patents at the end of 2011.[2] Before the IBM transaction, Yahoo had more than 3,300 patents and published patent applications.[3]
Redesigning the product was never on the table.
Ten days after Yahoo sued, Reuters reported that Facebook had agreed to purchase roughly 750 software and networking patents from IBM. Facebook and IBM did not publicly confirm the number, so the figure is a reported fact, not one established in the court record.[3]
On April 3, three weeks after Yahoo sued, Facebook answered and accused Yahoo of using ten Facebook patents without permission. The patents concerned search, advertising, photo tagging, and other web functions. Facebook’s SEC filing confirms the ten-patent response, although the filing does not establish that every patent came from IBM.[1]
Yahoo said it understood the strategy. In a later court filing, Yahoo alleged that Facebook had acquired many or all of those patents to retaliate in the lawsuit.[4] The allegation was never a judicial finding. The allegation still described the move: Facebook had found assets that mattered to Yahoo’s operating business and turned a one-sided threat into mutual exposure.
Facebook kept building the position. Later in April, Facebook agreed to pay Microsoft approximately $550 million for about 650 AOL patents and patent applications. The transaction also included rights across additional AOL patents that Microsoft retained.[5]
The lawsuit never reached a jury. The strategy made a jury unnecessary.
In early July, less than four months after Yahoo sued, the companies resolved every patent dispute. Facebook’s quarterly report records the July 6 settlement and no direct payment obligation. Yahoo’s annual report records the settlement and an expanded commercial relationship. Cooley reported that the cross-license required no direct cash payment.[6]
The public record does not establish that any single purchase caused Yahoo to settle. The record establishes that Facebook assembled several responses while the dispute was active: a defense, patent allegations against Yahoo, a reported IBM acquisition, and the AOL transaction.
Facebook did not prove Yahoo’s patents invalid. Facebook did not obtain a final ruling that its products fell outside Yahoo’s patents. Facebook changed what Yahoo risked by continuing the fight.
Facebook’s lesson does not depend on Facebook’s scale.
A smaller company may acquire one or two patents instead of hundreds. It may obtain a license, buy a product line, or identify patents already owned that matter to the other side. The strategic move is the same. An incoming patent demand does not define the available choices.
The company can change what the other side risks by continuing the dispute.
Standards-based industries apply the same principle at industrial scale. Companies participating in cellular, Wi-Fi, video, and other standards seek patents that other implementers may need. When competing manufacturers own mutually important positions, cross-licenses can allow both companies to continue selling products.[7]
A smaller operating company does not need a global standards portfolio. The company needs patents that matter to the particular businesses most likely to threaten it.
Synthes Changed Its Patent Language After Seeing Spinal Kinetics’ Product
Synthes began with a patent application for an artificial spinal disc. The original 2003 technical description showed fibers anchored to cover plates through grooves around the plates’ edges.
Spinal Kinetics later sold the M6-C and M6-L artificial discs. Those products used internal slots in the cover plates instead of peripheral grooves.
Synthes changed its pending application in February 2008, almost five years after the original submission. The new patent language referred broadly to a “plurality of openings.” The Federal Circuit record states that Synthes added the language after the M6 products were on the market and after Synthes had been advised that the M6 represented a significant technical improvement.[8]
The new phrase mattered. An internal slot could qualify as an opening even though the original description focused on grooves around the edge.
The Federal Circuit stated the governing principle plainly. A company may broaden pending patent language to capture a competitor’s product when the original technical description supports the broader language.[8]
Synthes failed because the original description did not support the new language.
The original description taught grooves. The jury found that the description did not show ownership of the broader idea of openings located anywhere on the cover plate. The Federal Circuit upheld the finding that the later patent language lacked support and was invalid.
Synthes had identified the correct competitive target. The weakness sat years earlier in the original application.
The case therefore proves two parts of the strategy. Pending applications can respond to products that appear after the original submission. The original technical description determines how far the later response can reach.
Liebel Broadened Its Position After Medrad Built a Jacketless Injector
Liebel-Flarsheim’s original patent language covered a front-loading medical-fluid injector with a pressure jacket in front of the syringe opening.
Medrad developed a different injector. Medrad’s product operated without the pressure jacket.
The Federal Circuit record states that Liebel learned about Medrad’s jacketless system while Liebel’s applications were still under review. Liebel then removed every express pressure-jacket requirement from the disputed patent language to bring Medrad’s injector within the patent’s reach. The patent office allowed the new language.[9]
Liebel achieved the immediate drafting goal. The broader language reached jacketless injectors.
The broader patent still needed technical support.
Liebel’s original description focused on injectors with pressure jackets. The company’s experiments with jacketless systems had been unsuccessful. Liebel engineers testified that a workable jacketless system was more than a routine design choice, and no jacketless prototype had been made or described when Liebel submitted the application.[9]
The Federal Circuit held the broadened patent invalid because the original description did not teach a skilled engineer how to make the full range that Liebel later demanded.
Liebel won the language fight and lost the asset.
Medrad’s product had revealed the exact commercial position Liebel wanted. The original application had not preserved the desired position. Later editing could not manufacture the missing technical foundation.
The Three Records Show a Repeatable Strategy
Facebook, Synthes, and Liebel used different tools at different moments. Each company used patents to support the outcome the business needed.
Facebook faced an active lawsuit. Facebook acquired assets and used patents that mattered to the other side. The company changed the negotiating position with resources available during the dispute.
Synthes and Liebel still had applications under patent-office review. Each company studied an operating competitor’s product and changed pending patent language to reach what the competitor had built. The courts recognized competitor-directed drafting as legitimate.
Both medical-device companies also discovered the same limit. A pending application preserves only the positions supported by its original technical description.
The repeatable strategy begins long before a dispute.
An early patent application should describe alternative architectures, locations, sequences, materials, actors, and control methods, covering the ways a competitor might preserve the customer benefit while changing the implementation. That technical depth gives later patent language somewhere solid to stand.
A live competitor map adds the second piece. Product releases, manuals, customer complaints, technical hiring, integrations, and market moves reveal which solutions are becoming important. IP strategy can then direct pending patent work toward observed commercial behavior instead of a hypothetical future.
Acquisition completes the menu when development cannot move fast enough. IP strategy may call for the company to buy the position the business needs, obtain permission, or assemble enough leverage to support a balanced negotiation.
Freedom to Invent Is Built Before the Patent Threat Arrives
Sophisticated companies do more than react to patent threats. They preserve choices before the threat appears.
They write early patent applications with enough technical depth to support later moves, and they keep selected applications open while the market develops. They watch competitor products for the technical decisions that matter, acquire rights when time is too short to create them, and build patents that matter to businesses they may someday face.
Early descriptions, open applications, competitor monitoring, and selective acquisitions do not eliminate risk. The preparations keep management in control when a patent threat appears.
The chain of command does not change. Management chooses the product and the business objective. IP strategy builds the position needed to support them. Patent attorneys execute the legal work they are given.
Facebook shows the power of acquired leverage. Synthes shows that patent language can respond to a competitor’s released product. Liebel shows why the original description must carry the position from the beginning.
Together, the cases turn Freedom to Invent from a slogan into an operating discipline.
Subscribe to BlueIron IP for more practical frameworks that connect patents to product strategy and competitive leverage.
1 Facebook, Amendment No. 4 to Form S-1, “Legal Proceedings” (Apr. 23, 2012). Facebook’s filing states the filing date, the number of Yahoo patents, the subject areas, the relief Yahoo sought, and Facebook’s April 3 patent allegations against Yahoo. ↩
2 Cooley, Yahoo v. Facebook. The article is a firsthand account by Facebook’s litigation counsel. It supplies the comparative portfolio figures and counsel’s account of the settlement. ↩
3 Reuters, Facebook buys 750 patents from IBM, source says (Mar. 22, 2012). Reuters attributes the IBM patent count and subject matter to a person familiar with the transaction and notes that Facebook and IBM did not comment. The same article, citing a U.S. government database, states that before the IBM transaction Yahoo had over 3,300 patents and published patent applications. ↩
4 Yahoo’s allegation appears in its court filing and is quoted by PCWorld in Yahoo Claims Facebook Bought Patents to Countersue It (Apr. 30, 2012). The article attributes motive to Yahoo because the allegation was not adjudicated. ↩
5 Facebook, Amendment No. 4 to Form S-1 (disclosing approximately 650 patents and applications, additional license rights, and approximately $550 million in cash); Microsoft, Microsoft, Facebook Announce Patent Agreement (Apr. 23, 2012). ↩
6 Facebook, Form 10-Q for the quarter ended June 30, 2012 (recording the July 6 settlement and no direct payment obligation); Yahoo, 2012 Form 10-K (recording the settlement and expanded commercial arrangements); Cooley, Yahoo v. Facebook (counsel’s account of the cross-license). ↩
7 Carl Shapiro, Navigating the Patent Thicket: Cross Licenses, Patent Pools, and Standard Setting; Federal Trade Commission, Antitrust and Intellectual Property Law: From Adversaries to Partners. ↩
8 Synthes USA, LLC v. Spinal Kinetics, Inc., 734 F.3d 1332, 1336–42 (Fed. Cir. 2013), Federal Circuit opinion. ↩
9 Liebel-Flarsheim Co. v. Medrad, Inc., 481 F.3d 1371, 1375–79 (Fed. Cir. 2007), Federal Circuit opinion. ↩
